We found that mice inoculated with 1 × 104 CCL16-overexpressing MDA-MB-231 cells demonstrated a dramatically increased incidence of tumor initiation versus mice inoculated with control cells and that CCR2 knockdown prevented this increased tumor incidence (Figure 7A). The gene discussed is CCR2; the disease is neoplasm.